Manitoba and Saskatchewan Promise to Make Life-Altering Dexcom G6 CGM System Accessible for Youngsters and Younger Adults with Kind 1 Diabetes

• The Dexcom G6 allows people with diabetes to manage their condition without fingersticks * or scanning

BURNABY, BC, April 16, 2021 / CNW / – Dexcom, Inc. (NASDAQ: DXCM), a leader in real-time continuous glucose monitoring (CGM), is pleased to announce that the governments of Saskatchewan and Manitoba Both recognized CGM for children and young adults with diabetes in their budgets last week.

On Tuesday April 6thth that Saskatchewan The government announced that it would cover the cost of CGM care for insulin-dependent children and adolescents under the age of 18. While on Wednesday April 7thth that Manitoba The government announced that it will launch a new program to cover CGM systems for people in the province with type 1 diabetes up to the age of 25. Currently only Yukon fully funds CGM for children and adults living with type 1 diabetes.

“We are passionate about the people and families in Saskatchewan and Manitoba Who can access this innovative technology that enables more effective diabetes management? However, individuals who receive intensive insulin therapies of all ages would also benefit from CGM funding, “he said Laura Endres, Vice President and General Manager of Dexcom Canada. “We appreciate the opportunity to work with health ministries in both provinces as Ministers Merriman and Stefanson are committed to the type 1 diabetes community. Dexcom aims to ensure CGM technology that can reduce the risk of costly long-term diabetes . ” Complications can be funded regardless of the age of the individual. ”

The Dexcom G6 CGM System uses a small, portable sensor and transmitter to continuously measure glucose levels and send them wirelessly to a compatible smart device † or receiver. Diabetics have access to real-time glucose data up to every five minutes. The Dexcom G6 also displays the direction and rate of change in glucose so users can make more informed decisions to proactively manage their glucose levels.

With a predictive urgency low-soon alarm, the Dexcom G6 can alert the user of severe hypoglycemia, leaving time to take appropriate action before it happens – day or night. Dexcom is clinically proven to lower CGM A1C, reduce hyper- and hypoglycemia, and increase time in the area (i.e., the percentage of time a person’s blood sugar level spends within a target range) .2,3

The Dexcom G6 CGM System is the only approved sensor glucose monitoring system Canada for children from two years. For more information on the Dexcom G6, please visit www.dexcom.com.

* If your glucose warnings and readings from the Dexcom G6 do not match symptoms or expectations, use a blood glucose meter to help make diabetes management decisions.

† A list of compatible devices can be found at www.dexcom.com/compatibility.

About Dexcom, Inc.

Dexcom, Inc. enables people to take control of diabetes through innovative continuous glucose monitoring (CGM) systems. Headquarters in San Diego, California in the The United Statesand with operations in CanadaDexcom has established itself as a leader in diabetes care technology. By considering the needs of users, carers and providers, Dexcom simplifies and improves diabetes management around the world. For more information on Dexcom CGM, please visit www.dexcom.com.

© 2021 Dexcom, Inc. Dexcom and Dexcom G6 are registered trademarks of Dexcom, Inc. in the United States and may be registered in other countries. All rights reserved.

References

SOURCE Dexcom, Inc.

For more information: Media contact: Alena Atkinson, 705.206.9991, Veritas Communications, [email protected]